- Guidelines for Substitution of a Different Formulation for a Prescribed Drug
- Dispensing the Appropriate Capsule Combination for the Daily Dose of Temozolomide
- Criteria for an Accurate Prescription of a Nebulized Bronchodilator
- Dispensing the Appropriate Tablet Combination for the Daily Dose of Xeloda (Capecitabine)
- Dispensing the Appropriate Number of Capsules of Succimer for Chelating Heavy Metals
- Determining the Appropriate Dose of Sevelamer Hydrochloride to Control Serum Inorganic Phosphorus Levels in Patients with End Stage Renal Failure
- Dispensing Sufficient Medication to Fill a Prescription
- Amount of Cream or Ointment to Dispense for Topical Skin Application
- Criteria for a Valid Prescription
- Determining the Price to Charge for a Prescription
- Calculation of the Weight of a Drug Compound to Dispense to Deliver a Target Dose of the Active Drug Moiety
- Food and Drug Administration (FDA) Rules for Importation of an Unapproved Drug
- Converting a Patient from Intravenous to Oral Drug Administration
- Dispensing Sufficient Oseltamivir to Treat a Patient for Influenza
- Reducing the Risk of Forged or Altered Prescriptions
- Dispensing Sufficient Voriconazole (Vfend) for Intravenous Infusion
- Dosing Nelfinavir mesylate (Viracept) for Oral Therapy in a Child
- Predictors of Miller et al Identifying a Patient with a Chronic Disease Who Comes to the Emergency Department for a Drug Refill
- When to Investigate a Generic Drug for Therapeutic Effectiveness
- Recommendations of the US Food and Drug Administration (FDA) on Selecting a Website from Which to Purchase a Prescription Medication Online
- Hazards of Buying Medications On-Line from an Unscrupulous Website
- Dispensing Sufficient Ulesfia Lotion (5% Benzyl Alcohol) for the Treatment of Head Lice
- Fingertip Unit (FTU) and Dosing of a Topical Cream
- Dosing a Saturated Solution of Potassium Iodide (SSKI)
- Patient Assessment and Instruction in the Use of an Inhaler
- Score of Ruscin and Semla for Evaluating a Patient's Ability to Perform Tasks Associated with Taking Tablets or Pills
- Dosage Forms Subscore of the Medication Regimen Complexity Index (MRCI)
- Dosing Frequency Subscore of the Medication Regimen Complexity Index (MRCI)
- Subscore for Additional Directions of the Medication Regimen Complexity Index (MRCI)
- Medication Regimen Complexity Index (MRCI)
- Impact of Numeracy on a Patient’s Ability to Take a Medication
- Identification of High Risk Medications
- Schedules for Controlled Substances
- Scale of Nutt et al for Assessing the Harm of a Drug's Misuse Potential
- Principles for Off-Label Use of a Medication
- Handling a Drug Shortage
- Information That Should Be Included in the Label Placed on a Sterile Product Prepared in a Pharmacy
- Reasons for a Drug Shortage
- Handling Glacial Acetic or Other Strong Acids
- Medication Appropriateness Index of Hanlon et al
- General Rules for Treatment of a Chronic Condition from the International Consensus Guidelines for the Therapy of Idiopathic Pulmonary Fibrosis
- Criteria for Unlabeled Use of a Medication (Off-Label Drug Use)
- The Geriatric Medication Evaluation Algorithm of Newton et al.
- Troubleshooting the Failure of a Patient to Respond to a Medication
- Summated Score of Samsa et al for the Medication Appropriateness Index of Hanlon et al
- Clinical Utility Score of Kain
- Comparison of Antiepileptic Drugs Using the Monostars Score of Brodie
- NO TEARS Tool for Medication Review
- Total Cumulative Drug Exposure Over Time
- Reasons Why an Antibiotic May Be Prescribed When Unnecessary
- 1997 Beers Diagnosis Independent Criteria to Identify Potentially Inappropriate Drug Use In an Elderly Patient
- Identifying Unnecessary Antibiotic Usage Near the End of Life
- CNS Penetration Effectiveness (CPE) Score for an Antiretroviral Drug Regimen
- Problems Listed by Rollason and Vogt Associated with Polypharmacy
- Pseudopolypharmacy
- Predictors of Nyhuis et al for Switching an Antipsychotic Medication in a Patient with Schizophrenia
- Criteria of Rapoport et al for Evaluating Triptan Therapy of Migraine
- Therapeutic Duplication
- Risk Factors for a Serious Complication in a Pediatric Patient Receiving of a Cough and Cold Remedy
- Risk Factors of Harugeri et al for High-Level Polypharmacy in an Elderly Hospital Patient
- Listing of Drugs with a Narrow Therapeutic Index from the North Carolina Board of Pharmacy
- Potentially High Risk Medications
- Drug Burden Index (DBI) of Hilmer et al (Total Drug Burden, TDB)
- Drug Holiday (On/Off Treatment, Strategic Treatment Interruption)
- A Checklist for Informing the Patient About a New Medication
- The MedTake Test for Determining a Patient's Familiarity with Medications
- A Patient Questionnaire Before Using Imitrex Nasal Spray for Migraine Headaches
- Risk Factors of Sorensen et al for a Poor Health Outcome Based On How a Patient Manages Medications at Home
- Dosing a Drug With an Additional Side Chain (Fosphenytoin and Phenytoin Equivalents)
- Effects of Hydration on Drug Dosage
- Dosing a Drug Formulated as a Salt
- Equivalent Anti-Inflammatory Oral or Intravenous Corticosteroid Dose
- Equivalent Narcotic (Equianalgesic) Drug Doses
- Converting a Patient with ADHD to Extended Release Methylphenidate
- Converting a Patient from Depakote to the Extended Release (ER) Formulation
- FDA Criteria for Therapeutic Equivalence Between Two Drug Preparations
- Converting a Patient Taking Intravenous Immune Globulin to Subcutaneous Immune Globulin (SCIG, Vivaglobin)
- Equivalent Doses of Theophylline and Related Methylxanthines
- Total Levodopa Equivalents (Levodopa Equivalent Daily Dose, LEDD)
- Dose Equivalents for Dopamine Agonists As Reported by Hobson et al.
- Equivalent Doses of Loop Diuretics (Furosemide Equivalents)
- FDA Therapeutic Equivalence Evaluation Codes
- Indications for Using Parenteral Morphine for Control of Severe Pain
- Method of Mercadante et al for Titrating Intravenous Morphine in a Patient with Severe Cancer Pain with Immediate Conversion to Oral Dosing
- Method of Nelson et al for Administration of Parenteral Morphine for a Patient with Severe Cancer Pain
- Method of Indelicato and Portenoy for Opioid Rotation in a Patient with Refractory Cancer Pain
- Conversion of a Patient to Oral Oxycontin According to the Physicians' Desk Reference (PDR)
- Management of Acute Pain in a Substance Abuser
- Dosing Tylenol (Acetaminophen) in Children
- Calculating the Aspirin Conversion Factor (ACF) for a Salicylate
- Calculating the Aspirin Equivalent Dose (AED) for a Salicylate
- Increase in Fentanyl Patch Strength to Adjust for Frequent Episodes of Breakthrough Pain
- Conversion of an Oral Morphine Dose to a Transdermal Fentanyl Patch Strength
- Features Suggestive of Drug Seeking Behavior in a Patient
- Risk Factors of Ives et al for Opioid Misuse in a Patient with Chronic Pain
- Patient Agreement with the Physician for the Use of Opioid or Other Controlled Substances
- Contraindications for the Use of a Fentanyl Transdermal Patch in a Patient with Pain
- Factors Associated with Toxic Symptoms in a Patient Taking Extended Release Oxymorphone
- Opioid Induced Hyperalgesia (OIH)
- Risk Factors for Fentanyl Toxicity in a Patient Treated with a Transdermal Patch
- Management of the Pain Associated with Diabetic Peripheral Neuropathy
- World Health Organization (WHO) Analgesic Ladder
- Prescription Opioid Misuse Index (POMI) of Knisely et al
- Conversion of a Patient from Intravenous to Transdermal Fentanyl
- Dartmouth-Hitchcock Medical Center Protocol for Dosing Fentanyl in an Adult Trauma Patient
- Clinical Criteria of Chabal et al for Prescription Opiate Abuse in a Patient with Chronic Pain
- Indications for the Use of Pregabalin in a Patient with Pain
- Guidelines of Huxtable for Reducing the Risk of Herbal Use
- Precautions for the Safe Use of Ephedrine and Related Alkaloids
- Food and Drug Administration (FDA) Criteria for Determining If a Herb or Food Supplement Make Claims for Use in a Disease
- Complications Associated with Fish Oil Therapy
- WHO Guidelines for Good Agricultural and Collection Practices (GACP) for Medicinal Plants: Harvesting the Plant
- Categories of Adverse Reactions Caused by an Herbal Remedy
- Carcinogens in Herbal Remedies
- Use of Valerian Root (Valeriana officinalis) and Its Withdrawal Reaction
- Risk of Infection Following Therapy with a Naturopathic Medicine
- FDA Categories of Drugs for Use in Pregnancy
- Splitting Pills and Tablets
- Maximal Use of Liquid Drug in Vials
- Issues Affecting Outcome in Insurance Company Directed "Brown Bagging" of Chemotherapeutic Agents
- Tablets That Should Not Be Split
- Prevention of Prescription Errors for Controlled Substances
- Prescription Abbreviations Associated with Dosage Errors
- The National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) Categories for Medication Errors
- Risk Factors for Medication Errors Identified by the American Society of Hospital Pharmacists (ASHP)
- Risk Factors in Pharmacy Practice on Dispensing Errors
- Reasons for Prescription Medications Being Wasted in Geriatric Outpatients
- Risk Factors of Fialova et al for Inappropriate Medication Use in Elderly European Home Care Patients
- Risk Factors Shi et al for a Patient to Inappropriately Use Over-the-Counter Phenazopyridine (Pyridium)
- Types of Drug Diversion for a Controlled Substance
- Classification of Manchikanti for Troubled Providers Who Write Prescriptions for Controlled Substances
- Recommendations of Argo et al for Reducing Serious Medication Errors
- Prevention of Medication Errors in the Use of Drug Look-Alikes
- Ways In Which a Patient May Accumulate a Large Supply of a Prescription Drug
- Recommendations of Koren and Haslam for Reducing Tenfold and Other Dose Calculation Errors
- Risk Factors of Li et al for a Parent Giving an Inadequate Dose of an Antipyretic Agent to a Child
- Risk Factors of Moyen et al for Medication Errors in the Intensive Care Unit (ICU)
- Risk Factors of Valentin et al for Errors in the Administration of Parenteral Medications in the Intensive Care Unit (ICU)
- Dose Dumping
- Sources for Error in a Medication Dosage Equation Based on the Report of Lesar
- Determinants of Lu and Roughead for Patient-Reported Medication Errors
- The 7 C’s of Routledge for Safe Prescribing (and Avoiding a Titanic Error)
- Selection of Sites for Self-Injection of Interferon-beta
- Safety Guidelines for Patients Taking Chemotherapy Agents at Home
- Intracavernosal Injection of Prostaglandin E1 by a Man with Erectile Dysfunction
- Anticoagulation Using Subcutaneous Injection of Enoxaparin (Low Molecular Weight Heparin)
- Intranasal Administration of Desmopressin Acetate
- Subcutaneous Injection of Insulin
- Testosterone Buccal System with Mucoadhesive (Striant)
- General Instructions for Handling a Transdermal Therapeutic System (Drug Patch)
- Instructions for Withdrawal of a Parenteral Dose from a Drug Vial
- Instillation of Ofloxacin Otic Drops for an Ear Infection
- General Instructions for a Patient Taking an Oral Bisphosphonate for Osteoporosis
- Instructions for Application of a Vaginal Cream
- Instructions for Administration of a Nasal Spray
- Administration of Diazepam Rectal Gel (Diastat AcuDial) to a Patient with a Seizure Disorder
- Handling Problems Associated with Self-Injections
- Instructions for Handling a Potentially Toxic Medication at Home
- Inspecting the Vial of an Injectable Preparation Prior to Withdrawing a Dose
- Determining If a Patient is a Candidate for Patient Controlled Analgesia (PCA)
- Patient Controlled Analgesia (PCA) By Proxy
- Hazards of Administering a Medication in a Plastic or Styrofoam Cup
- Use of a Miconazole Buccal Table (Oravig) for the Treatment of Oropharyngeal Candidiasia
- Preventing Secondary Exposure Following Cutaneous Application of Testosterone Gel
- Estimating Shelf-Life of a Drug Using the Q10 Method
- Assessing Drug Potency After the Expiration Date
- Methods to Detect Thawing of a Frozen Solution
- Evaluation of a Medication for Deterioration After Exposure to the Environment
- Problems Associated with the Freezing of Medications
- Precautions in the Dosing and Storage of Paraldehyde
- Deterioration of Aspirin (Acetylsalicylic Acid)
- Deterioration of Epinephrine in an Autoinjector (EpiPen) After the Expiration Date
- Significance of an Unexpected Odor from a Medication
- Potential Hazards of Storing a Drug in a Container Different from the One Used to Dispense It
- Storage of Nitroglycerin Tablets
- Storage and Handling of Dabigatran etexilate mesylate (Pradaxa)
- Expiration Date for a Multi-Dose Medications Vial
- Drug Deterioration Due to Light Exposure
- The Density Factor Method for Preparing a Medicated Suppository
- The Occupied Volume Method for Preparing a Medicated Suppository
- Amount of Surfactant Required to Emulsify an Oil
- Blending Two Surfactants to Achieve a Mixture with a Specific Hydrophile-Lipophile Balance (HLB)
- Solubility of a Drug That is the Salt of an Acid
- Determining the pH to Dispense a Solution of a Salt of an Acidic Drug for Optimum Solubility
- Dose Solubility Ratio
- Descriptive Terms for Solubility of a Solute in a Solvent
- Biopharmaceutical Classification Scheme (BCS) for Bioavailability of a Drug After Oral Administration
- Placebo and Nocebo Effects
- NIH Recommendations for Preparation of Parenteral Antineoplastic Agents
- NIH Recommendations for Administration of Parenteral Antineoplastic Agents
- Risk Level Classification of the American Society of Health-System Pharmacists (ASHP) for Pharmacy-Prepared Sterile Products
- Monitoring a Person Who Handles or Administers Parenteral Antineoplastic Agents
- Errors That May Occur When Compounding a Prescription
- Indications for Preparing a Compounded Medication
- Reasons for the FDA to Initiate an Enforcement Action Against a Compounding Pharmacy
- Recommendations of Mattner and Gastmeier for Reducing the Risk of Bacterial Contamination of a Multiple-Dose Vial
- Red and Yellow Flags Associated with a Compounded Product
- Problems Caused by Child-Resistant Packaging for the Elderly
- Problems Caused by Tamper-Resistant Packaging for the Elderly
- Measuring the Moisture Permeability of a Container for Multiple Tablets or Capsules
- Indications of Tenenbein for Selecting Unit Dose Packaging of a Medication
- Testing a Tablet's Durability in a Friabilator
- Crushing Tablets and Mixing the Powder with Food for Drug Administration to Adolescents and Adults
- Crushing Tablets or Capsules for Drug Administration to an Infant
- Hard Capsule Size and Volume
- Reasons to Coat a Tablet
- Estimating the Vapor Pressure of a Mixture of Two Liquified Gas Propellants
- Determining the Ratio of Two Liquified Gas Propellants to Deliver a Specific Vapor Pressure for an Aerosol
- Effect of Particle Size on the Site of Deposition in the Respiratory Tract
- Factors Affecting the Effectiveness of Aerosol Therapy
- Fractional Deposition of Inhaled Particles
- Predicting a Medically Significant Reaction in Pediatric Patients Receiving an Infusion of Infliximab
- Algorithm of Sandborn and Hanauer for Administering Infliximab to a Patient with Crohn's Disease
- When to Suspect the Formation of Anti-Infliximab Antibodies in a Patient
- Contraindications for the Use of Infliximab (Antibody to Tumor Necrosis Factor alpha)
- Nomenclature for Therapeutic Antibodies
- Immune Reconstitution Inflammatory Syndrome (IRIS) Following Discontinuation of a Tumor Necrosis Factor alpha (TNF alpha) Blocking Agent
- Approved Indications for the Use of Etanercept (Enbrel)
- Decision Tree of McKinnon and Avis for Selection of a Filter System for Pharmaceutical Preparation
- Dosing and Administration of Pulmonary Surfactant (Survanta, Beractant)
- Determining the Infusion of Epoprostenol Sodium (Flolan) for a Patient with Pulmonary Hypertension
- Dosing Xolair (Omalizumab) in a Patient with Asthma
- Determining the Dose of Sotalol in an Adult Patient to Control Atrial Fibrillation or Flutter
- Determining the Dose of Sotalol in a Pediatric Patient to Control Atrial Fibrillation or Flutter
- Maintenance Dosing of an Adult Patient with Atrial Fibrillation or Flutter Receiving Sotalol
- Determining the Regimen of Integrilin (Eptifibatide) for a Patient with an Acute Coronary Syndrome
- Adjusting the Dose of Eplerenone (Inspira) for a Patient with Congestive Heart Failure Based on the Serum Potassium
- Precautions in Dosing Mitoxantrone for Patients with Multiple Sclerosis
- Switching from Oral Rivastigmine (Exelon) to the Transdermal Patch in a Patient with Alzheimer's Disease
- The STEPS (System for Thalidomide Education and Prescribing Safety) Program of Celgene Corporation for Thalidomide
- The SMART (System to Manage Accutane Related Teratogenicity) Program of Roche Pharmaceuticals for Isotretinoin
- Precautions in the Exposure to Ribavirin in a Patient of Reproductive Age
- Determining the Amount of Sodium Chloride to Add to an Ophthalmic Solution to Make It Isotonic With Normal Tears
- Depot Method for the Application of Topical Ophthalmologic Medication
- Number of Drops of an Ophthalmologic Medication to Apply
- Criteria for an Ideal Preservative in a Topical Preparation
- Method of Application for a Cream or Ointment
- Rule of 5 by Lipinski et al for Identifying a Drug with Poor Oral Absorption
- Oral Absorption of an Azole for Antifungal Therapy in a Patient with Hypochlorhydria or Achlorhydria
- Impact of Gastroparesis on Oral Drug Therapy
- Absorption of an Oral Drug in a Patient Ingesting Activated Charcoal
- Altered Drug Absorption Following Bariatric Surgery
- Determining the Amount of Medication Remaining in a Metered-Dose Inhaler Canister
- Estimating the Number of Days Left for a Metered-Dose Inhaler Canister Based on Daily Usage Pattern
- Dosage Preparation for Continuous Bronchodilator Therapy (CBT) Delivered by a Nebulizer
- Recommended Excess Volume for an Injectable Preparation
- USP/NF Guidelines for Testing Injectable Preparations for Particulate Matter
- Complications of a Drug Preparation Injected Into the Central Nervous System Secondary to a Preservative or Particulate Matter
- Risk Factors for Buying a Counterfeit Drug
- Hazards Associated with Use of a Counterfeit Drug
- How to Detect a Counterfeit Drug
- Advice to Travelers for Carrying Medications and Administration Supplies
- Drugs That Are Absorbed Out of the Infusion Solution Onto the Infusion Set
- Drug Refill Gap
- Medication Possession Ratio (MPR)
- Dosing Imodium (Loperamide HCl)
- Dosing Methylnaltrexone (Relistor) for a Patient with Opioid-Associated Constipation
- Guidelines for Donating Drugs During a Disaster
- Dosing of Levothyroxine Sodium for a Pediatric Patient with Hypothyroidism
- Dosing Zemplar (Paricalcitol) Capsules for a Patient with Secondary Hyperparathyroidism in Chronic Kidney Disease
- Complications Associated with Long-Term Hormone Implants
- Preparation of a Diluted Alcohol Solution (Vol/Vol) from 94.9% Alcohol
- Properties of a Medication Suitable for Transdermal Administration
- Ways to Enhance Absorption of a Drug After Transdermal Administration
- Impact of Temperature on Absorption from a Transdermal Patch
- Medication Errors Associated with Transdermal Rivastigmine (Exelon) Patches in Patients with Alzheimer's Disease
- Possible Consequences of Drug Therapy Discontinuation
- Reasons for Failing to Detect a Pyrogen in a Pharmaceutical Preparation
- USP Rabbit Pyrogen Test
- Orphan Drug
- Problems in Disposing Pharmaceuticals By Flushing Down a Toilet or Into a Sewer
- Hazards of Not Disposing of Outdated or Unused Drugs
- Disposal of an Outdated or Used Fentanyl Transdermal Patch
- Gluten in a Medication Given to a Patient with Celiac Disease
- Taste Masking for an Oral Medication
- Medication Intolerance Associated with Lactose Intolerance
- Medication Factors Contributing to Diarrhea Following Administration by an Enteral Feeding Tube
- Impact of Enteral Tube Placement on the Action of a Drug Administered by an Enteral Feeding Tube
- Administration of Phenytoin By Enteral Feeding Tube
- Problems Associated with Administering Drugs by an Enteral Feeding Tube
- When Rectal Administration of a Drug Should Be Considered
- Recommendations of Warren for Rectal Drug Administration
- Ceiling Effect
- Patient Assistance Programs (PAP)
- Pharmaceutical Care Index (PCI)
- Differential Diagnosis of Failure to Respond to an Injection of Botulinum Toxin
- Comorbid Conditions That May Increase the Risk of Adverse Effects Following Injection of Botulinum Toxin
- Reasons a Drug Company May Develop a New Drug When an Effective Therapy Is Present
- Barriers to Medication Reconciliation at Hospital Admission
- Types of Discrepancies in Medications and Instructions At Hospital Discharge
- Risk Factors Contibuting to Discrepancies in Medications and Instructions At Hospital Discharge
- Risk Factors of Unroe et al Associated with Discrepancies During Medication Reconciliation at Hospital Admission
- Dose Calculation and Administration of Kcentra
- Dosing the SSRI Citalopram Hydrobromide (Celexa)
- Barriers to Drug Therapy in an Elderly Patient
- Medications to Avoid in a Patient at Risk for Delirium
- Reformulation of Opioid Analgesics to Reduce Abuse Potential (Tamper-Resistant Formulation, TRF)
- Classification of Booth et al for Prescribing Errors in the Pediatric Intensive Care Unit
- Recommendations of Booth et al for Preventing Prescribing Errors in the Pediatric Intensive Care Unit (Zero Tolerance Prescribing)
- Risk Factors of Teunissen et al for Medication Administration Time Errors
- Medication Errors Identified by Eginger et al in Highly-Active Antiretroviral Therapy (HAART) for a Hospitalized Patient
- Reducing Medication Errors due to Look-Alike Drug Names Using Capital (“Tall Man”) Letters
- Guidelines of Bygum et al for Self-Administration of C1 Esterase Inhibitor (C1-INH) By Intravenous Infusion
- Benefits of Subcutaneous Self-Injection of FSH and HCG in a Male with Hypogonadotropic Hypogonadism
- Application of Benzocaine Gel for the Temporary Relief of a Toothache
- Cutaneous Application of Testosterone Gel for Transdermal Absorption
- Clinical Features of an Infusion Reaction to Infliximab
- Risk Factors of Kapetanovic et al for an Infusion Reaction to Infliximab in an Adult with Rheumatoid Arthritis
- Improving Gastrointestinal Absorption of Griseofulvin After Oral Dosing
- Decreased Gastrointestinal Absorption of Ciprofloxacin Associated with Calcium and Other Cations
- Dose Adjustment in for AndroGel (Topical Testosterone Gel)
- Methods That a Drug-Impaired Healthcare Worker May Use to Divert Drugs
- Problems in Home-Administered Medications Identified by Walsh et al
- Total Lifetime Dose of a Drug
- Drug-Related Errors of Urbina et al for a Hospitalized Patient
- Screening Tool to Alert Doctors to the Right Treatment for an Older Adult (START)
- Prescription Errors of Al Khaja et al for Acetaminophen (Paracetamol) in Infants
- Intravenous Administration of Acetaminophen for Post-Operative Analgesia
- Dosing Protocol of Fusco et al for Intravenous Acetaminophen
- Hazards of Taking an Herbal Remedy During Cancer Chemotherapy
- Errors Associated with Reconstituting an Injected Medication
- Drug Hoarding (Medication Hoarding)
- High Potency Active Pharmaceutical Ingredients (HPAPI)
- Data Collection for Oral Medication Identification
- Age-Adjusted Dose Regimen of Laer et al for Sotatol a Pediatric Patient with Supraventricular Tachycardia
- When to Be Cautious in Dealing with a Supplier of a Pharmaceutical Product
- FDA Score for Adhesion of a Transdermal Patch
- Octanol to Water Partition Ratio (Kow and log P)
- Criteria of Braun et al for an Adequate Therapeutic Trial of an NSAID in a Patient with Ankylosing Spondylitis
- Handling Problems in Children Who Have to Swallow Pills
- Accuracy of an Oral Liquid Measuring Device
- Score of Tatham et al for Grading Eye Drop Instillation Technique
- Risk Factors for Improper Eye Drop Administration
- Deprescribing
- Tolerance and Tachyphylaxis
- Herbal Interactions with Analgesic Drugs
- Adverse Effects of Santonin (Derived from Artemisia maritima)
- Toxicity of the Oleoresin of Aspidium (Wood Fern)
- Potential Dosing Errors When Switching Between Drug Formulations
- Problems Associated with the Home Medicine Cabinet
- Complications of Tetracycline Degradation Products
- Criteria of McLeod et al for Inappropriate Prescribing in an Elderly Patient: Basic Principles
- Criteria of McLeod et al for Inappropriate Prescribing in an Elderly Patient: Drugs for Cardiovascular Disease
- Criteria of McLeod et al for Inappropriate Prescribing in an Elderly Patient: Analgesic Drugs
- Criteria of McLeod et al for Inappropriate Prescribing in an Elderly Patient: Psychotropic Drugs
- Criteria of McLeod et al for Inappropriate Prescribing in an Elderly Patient: Miscellaneous Drugs
- Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Psychotropic and CNS Drugs
- Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Gastrointestinal and Genitourinary Disorders
- Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Respiratory and Endocrine Disorders
- Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Musculoskeletal and Pain Disorders
- Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Cardiovascular Disorders
- Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Drugs That Increase the Risk for Falls
- Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: General Principles
- Double and Pseudo-Double Medications
- Underprescribing a Medication
- Value-Based Pricing Index (VBPI) of Dranitsaris et al for a New Drug to Treat Metastatic Colorectal Carcinoma
- Impact of Impaired Vision on the Ability of an Older Adult to Take Medications
- Pillbox Ratio
- Algorithm of Her et al for Evaluating the Appropriateness of Overriding an Alert for a Nonformulary Medication in a Computerized Prescriber Order Entry (CPOE) System
- Therapeutic Index (TIX) of Schafer et al for Comparing Intransal Corticosteroids for Management of Allergic Rhinitis
- Classification of Neville et al for Prescription Errors
- Pediatric Dosing Errors During Prehospital Emergency Care
- Recommendations of Farrell et al for Deprescribing Proton Pump Inhibitors (PPIs)
- Pill Burden
- Frequency of Medication-Related Preventable Hospital Readmissions Based on the Study of Pellegrin et al
- Risk Factors of Ruiz et al for Hospital Readmission for an Adverse Drug Reaction (ADR)
- Risk Factors of Leendertse et al for a Preventable Medication-Related Hospital Admission
- Conversion Factors of van Leeuwen et al for Vitamin K Antagonist Doses (Acenocoumarol, Phenprocoumon and Warfarin)
- Risk Scores of Layton et al for Dependence and Aberrant Behaviors for a Patient Starting a Pain Medication
- Topical Morphine or Opiate Cream or Gel for a Painful Cutaneous Ulcer
- Therapeutic Errors in Older Adults Identified by Hayes et al
- Errors in the Dosing of Ocaliva (Obeticholic Acid) in a Patient with Primary Biliary Cholangitis (PBC)
- Child-Resistant (C-R) Packaging
- Desiccants and Sorbents
- Dosing Sustained-Release Donepezil in Koreans with Alzheimer's Disease
- Decreased Absorption of Orally Administered Drugs Due to Sodium Polystyrene Sulfonate (Kayexalate)
- Potential Impact of Cholestyramine, Colestipol or Other Bile Acid Binding Resin on Drug Absorption
- Hypersensitivity Reaction to Milk Protein in Lactose Used As a Drug Excipient
- PRN (Pro Re Nata, As Needed) Prescription
- Duke Medication Assist Scale of Jamerson et al (Older Adults Medication Assist Scale)
- Drug Regimen Unassisted Grading Scale (DRUGS) of Edelberg et al
- Functional Tasks of Wilbur and Wong for Evaluating the Ability of a Patient to Cope with Medication Packaging
- Medication Management Ability Assessment (MMAA) of Patterson et al
- Deprescribing a Benzodiazepine
- Risk Factors of Gerlach et al for Long-Term Benzodiazepine Use in an Older Adult
- HEEADSSS Assessment of Jones et al for an Adolescent Receiving Long-Term Anticoagulation Therapy
- Dose Equivalence of Antiparkinsonian Drugs in Japan
- Dose Equivalence of Antidepressants in Japan
- Dose Equivalence of Anxiolytics, Sedatives and Hypnotics in Japan
- Dose Equivalence of Oral Antipsychotic Drugs in Japan
- Dose Equivalence of Shorting-Acting Injectable Antipsychotic Agents in Japan Versus Oral Chlorpromazine
- Dose Equivalence of Oral versus Injectable Formulations of Short-Acting Antipsychotic Agents in Japan
- Dose Equivalence of Long-Acting Injectable Antipsychotic Agents in Japan
- Hazards Associated with an Herbal or Alternative Therapy
- Self-Medication
- Use of Herbal or Alternative Therapy During Pregnancy
- Counterfeit Herbal or Alternative Medicine Ingredient
- Dosing Recommendations of Lalau et al for Metformin in a Patient with Type 2 Diabetes and Stage 3 or 4 Chronic Kidney Disease (CKD)
- Rebound of Multiple Sclerosis (MS) After Discontinuation of Natalizumab (NTZ)
- Disposal of Outdated or Unwanted Pharmaceuticals in the Trash
- Risk Factors for Misunderstanding a Medication Label
- Complications of Long-Term Benzodiazepine Therapy
- Deprescribing Medicines for a Patient in Palliative Care or with Limited Life Expectancy
- Dose Equivalence for Erythropoiesis-Stimulating Agents (Recombinant Erythropoietin, Epoetin Beta, Darbepoetin Alfa)
- Opioid Risk Tool of Webster and Webster
- Aberrant Behaviors of Webster and Webster for a Patient Seeking Opioids for Pain
- Revised Opioid Risk Tool of Cheatle et al
- Polyherbal Therapy
- Compounded Topical Pain Creams
- Rebound Insomnia Following Discontinuation of an Hypnotic Agent
- Reaction to Sorbitol by a Patient with Hereditary Fructose Intolerance
- Medication Fall Risk Score of Beasley and Patatanian
- Self-Medication with Activated Charcoal
- Chlorine Dioxide (Miracle Mineral Solution, Miracle Mineral Supplement)
- Causes of Nontherapeutic INR in a Patient Receiving Warfarin for Deep Vein Thrombosis (DVT)
- Discontinuation of Beta-Blocker Therapy in a Hospitalized Patient with Cirrhosis and Ascites
- Disposal of an Aerosol Can or Cannister
- Cholestyramine in Hyperthyroidism
- Resins for Absorption and Removal of Bile Acids from the Gastrointestinal Tract
- Predictors of Brant et al for Oversedation of a Hospitalized Patient
- Maximum Tolerated Dose (Maximal Tolerated Dose, MTD)
- DIRE Score of Belgrade et al for Outcome of Opioid Therapy of Chronic Noncancer Pain
- Classification of Von Korff et al for Opioid Therapy for Non-Cancer Pain
- Questionnaire of Skala et al for Predicting Addiction to Opioid Analgesics
- Risk Factors of Boscarino et al for Drug Dependency in an Outpatient with Noncancer Pain Treated with Opioids
- Current Opioid Misuse Measure (COMM) of Butler et al
- Screener and Opioid Assessment for Patients with Pain (SOAPP)
- Hypoglycemia Associated with a Dietary Supplement for Male Enhancement
- Prescribing for a Patient with Decompensated Cirrhosis
- Risk Factors for Opioid and Benzodiazepine Co-Prescription
- Scale of Dean and Barber for Scoring the Severity of a Medication Error
- Prescribing a Proton Pump Inhibitor (PPI) for a Patient with Cirrhosis
- Nomogram of Lamberink et al for Predicting Seizure Recurrence After Discontinuing of Antiepileptic Drug (AED) Therapy
- Prognostic Index of the Medical Research Council (MRC) for Seizure Recurrence After Apparent Remission
- Discontinuation of Diuretic Therapy
- New Gastrointestinal Binders for Hyperkalemia: Patiromer and Sodium Zirconium Cyclosilicate
- Colestimide
- Nitrosodimethylamine (NDMA, Dimethylnitrosamine)
- Cumulative Steroid Dose
- Defined Daily Dose (DDD)
- Dosage Categories of a Beta-Blocking Drug
- Opioid Risk Tool (ORT) of Webster and Webster for Predicting Drug Misuse in a Patient Receiving Opioids for Chronic Pain
- Risk Factors of Edlund et al for Opioid Abuse by Veterans With Chronic Non-Cancer Pain (CNCP)
- Risks Associated with Long-Term Opioid Therapy in an Older Adult
- Ingestion of Potassium Nitrate (Saltpeter)
- Medications Errors Associated with Pediatric Chemotherapy
- Hazards of Veterinary Drugs to Humans
- Signs That an Animal Owner May Be Abusing the Animal's Medications
- Findings Suggestive of Controlled Drug Diversion in a Veterinary Practice
- Castor Oil
- Criteria for an Over-the-Counter (OTC, Nonprescription) Drug
- Reasons Why a Drug May Be of Poor Quality
- Pediatrics Omission of Prescriptions and Inappropriate Prescriptions (POPI): Pulmonary and Gastrointestinal Tract
- Pediatrics Omission of Prescriptions and Inappropriate Prescriptions (POPI): Skin Disorders and Insects
- Pediatrics Omission of Prescriptions and Inappropriate Prescriptions (POPI): Neurologic Drugs
- Pediatrics Omission of Prescriptions and Inappropriate Prescriptions (POPI): Miscellaneous Drugs
- Traits of People Who Experiment with Alternative Therapies
- Wearing Off
- Risk Factors of Raja et al for Wearing-Off in Parkinson's Disease
- Distant Spread of Botulinum Toxin
- Dose Units for Botulinum Toxin
- Psychotropic (Psychoactive) Drugs
- Classes of Antiarrhythmic Drugs
- Medicines Optimisation Assessment Tool (MOAT) of Geeson et al for Preventing Medication-Related Problems
- Inappropriate Combination Therapy for Arterial Hypertension
- Appropriateness Rating Scale for a Therapy
- Polypharmacy and Drug Burden in HIV-Positive Adults
- Risk Factors of Rasool et al for Medication Errors for a Patient with Chronic Disorders
- Risk Factors of Weant et al for Medication Errors in the Emergency Department
- Safety Checks of Weant et al for Preventing Medication Errors
- Medication Errors of Peth: Prescription Errors
- Medication Errors of Peth: Ways to Reduce Transcription Errors
- Medication Errors of Peth: Dosing and Dispensing Safety Checks
- Medication Errors of Peth: Administration Errors
- Medication Errors of Peth: Monitoring Errors
- Risk Factors of Ramadanov et al for Medication Errors in Prehospital Care
- Risk Factors of Walsh et al for Medication Errors Affecting Pediatric Patients at Home
- Risk Factors of Martins et al for Inadequate Medicine Home Storage
- Causes of Drug Wastage
- Hazards Associated with Aerosols of Chemotherapy Fluids
- Organoleptic Evaluation
- Tapering a Drug Dose
- Pill Aversion
- Drug Sparing (Steroid-Sparing, Other)
- Polypharmacy and Other Risk Factors for 30-Day Hospital Readmission in a Geriatric Medical Patient
- Milligram Morphine Equivalent (MME) in Chronic Pain Management
- Indications for Referring a Chronic Pain Patient to a Pain Specialist
- Indications for Discontinuation of Opioid Therapy in a Chronic Pain Patient
- Red Flags for Possible Opioid Misuse in a Chronic Pain Patient
- MidMichigan Opioid Risk Assessment (MORA) for Risk of Adverse Events from Opioid Therapy
- Opioid Therapy in Patients with Comorbid Conditions
- Indications to Prescribe Naloxone for a Chronic Pain Patient Treated with an Opioid
- Instructions for Patients About Storage of Opioids in the Home and Their Disposal
- Conversion of a Chronic Pain Patient from an Opioid to Methadone
- Conversion of a Chronic Pain Patient from an Opioid to Fentanyl Patch
- Adverse Effects of Opiate Therapy in a Pain Patient
- Transdermal Buprenorphine for a Patient with Chronic Pain
- Buccal Buprenorphine for a Patient with Chronic Pain
- Violations of a Patient and Clinician Agreement for Opioid Therapy
- Patient and Drug Agreement with Expectations Prior to Starting Opioid Therapy for Chronic Pain
- Operational Tasks When Starting a Chronic Pain Patient on Opioid Therapy
- Sublingual Buprenorphine for a Patient with Chronic Pain: Switching from a Short-Acting Opioid
- Sublingual Buprenorphine for a Patient with Chronic Pain: Switching from an Intermediate-Acting Opioid
- Sublingual Buprenorphine for a Patient with Chronic Pain: Switching from an Long-Acting Opioid
- Discontinuation of Opioid Therapy in a Chronic Pain Patient
- Checklist for Follow-Up Visits by a Chronic Pain Patient
- Monitoring the Prescription Drug Monitoring Program (PDMP) Database in a Chronic Pain Patient
- Assuming Care of a Chronic Pain Patient Already Receiving Opioids
- Prediction of Methadone Serum Trough Concentration from the Daily Dose
- Individualized Treatment Plan for a Chronic Pain Patient
- Managing the Prescription for Opioids
- Initial Assessment of a Chronic Pain Patient
- Selecting Opioid Therapy for a Chronic Pain Patient
- Differential Diagnosis of a Failure in Pain Control with an Opioid
- Risk Factors of Eslami et al for Medication Errors in a Neonatal Intensive Care Unit (NICU)
- Medication Errors of Kassem et al Related to Prescriptions for Outpatient Pediatric Patients
- Contamination of Environmental Surfaces with Antineoplastic Drugs
- Polypharmacy and Emergency Readmission to the Hospital After Critical Illness
- MERIS (Medication Risk Score) of Saedder et a for Evaluating the Risk of a Drug-Related Problem
- Association of Polypharmacy and Malnutrition in Older Adults
- Model of Tang et al for Predicting Polypharmacy in a Community-Dwelling Elderly Patient
- Criteria of Phadke for Appropriateness of Prescribing
- NORGEP Criteria for Potentially Inappropriate Prescribing in the Elderly
- Cancer Opioid Risk Score
- Toxic Cough Syrup
- Medication Reconciliation Risk Stratification Tool of Chu et al: Score 1
- Medication Reconciliation Risk Stratification Tool of Chu et al: Score 2
- Z-Drug Hypnotics
- Guidance of Gradalski for Deprescribing and Prescribing for a Patient Starting Palliative Care
- Prescribing Cascade
- Types of Failures in the Use of a High-Risk Medication Associated with Preventable Hospital Admissions
- Criteria of Dreischulte and Guthrie for High-Risk Prescribing
- Algorithm of Lee et al for Deprescribing for a Patient with Rheumatoid Arthritis
- Barriers for Deprescribing Medications
- Indications for Opioid Rotation
- Drug Interactions Associated with St. John's Wort
- Causes of Medication Errors for the Home Care Patient
- Systemic Absorption from a Topical Drug
- Care and Use of a Spacer Device
- Counterfeit Sildenafil and Other Phosphodiesterase Type 5 Inhibitors
- Deprescribing Psychotropic Drugs for a Patient with Intellectual Disability
- Risk Factors of Schonenberger and Meyer-Massetti for Medication-Related 30-Day Readmission for an Adult
- Emergency Medicine Pharmacy Intensity Score Tool (EMPIST)
- Adverse Effects Associated with Tea Tree Oil
- Predictors of Tsukiyama et al for Early Discontinuation of Anamorelin for a Patient with Cancer-Associated Cachexia
- Predictors of Brandt et al for Relapse of Psychosis Following Discontinuation of Paliperidone
- Clinical Findings Following Clozapine Discontinuation
- Nomograms of Ferreira-Atuesta et al for Withdrawal of Antiseizure Medications After Epilepsy Surgery: Nomogram A for Seizure Freedom
- Nomograms of Ferreira-Atuesta et al for Withdrawal of Antiseizure Medications After Epilepsy Surgery: Nomogram A for Complete Seizure Freedom
- Environmental Contamination with Pharmaceuticals
- Potential Problems When Delivering a Medication By a Feeding Tube
- Dosing Propofol in Pediatric Patients Using the Equations of van Dijk et al: Induction Dose
- Adverse Effects of a Drug Shortage
- Risk Factors of SanFilippo et al for 30-Day Readmission for an Older Adult Discharged Home
- Polypharmacy in a Patient with Impaired Renal Function
- Implications of Polypharmacy in an Older Adult with HIV According to Kosana et al
- Michigan Opioid Safety Score (MOSS)
- Pasero Opioid Sedation Scale (POSS)
- Risk Factors for Over-Sedation from Opioids
- Opioid Sedation Scale of Macintyre et al
- Gummies (Chewable Gels)
- Counterfeit Botulinum Toxin (Botox, Dysport)
- Water Activity (Aw) of Pharmaceuticals
- Carbohydrate Content of Medications
